Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T8HR
|
||||
Former ID |
DNCL002468
|
||||
Drug Name |
Naptumomab estafenatox
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 2/3 | [521947] | ||
Company |
Active Biotech
|
||||
CAS Number |
CAS 676258-98-3
|
||||
Target and Pathway | |||||
Target(s) | 5T4 ONCOFETAL antigen | Target Info | Immunomodulator | [532633] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.